Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tepper

Showing results (401-410 of 432) with videos related to

Pageof 44
Sort By:
Headache|March 16, 2013
Ictal adiponectin levels in episodic migraineurs: a randomized pilot trialB Lee Peterlin, Gretchen E Tietjen, Barbara A Gower, et al.
Headache|December 14, 2020
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2Hans-Christoph Diener, Michael J Marmura, Stewart J Tepper, et al.
Frontiers in Neurology|August 21, 2024
Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodiesAni C Khodavirdi, Jasjit K Multani, Sam S Oh, et al.
Cancer|August 1, 1983
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremitiesS A Rosenberg, J Tepper, E Glatstein, et al.
The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Frontiers in Neurology|March 13, 2023
Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled studyRigmor H Jensen, Henrik Winther Schytz, Cristina Tassorelli, et al.
JAMA Neurology|May 19, 2025
Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical TrialRigmor H Jensen, Cristina Tassorelli, Stewart J Tepper, et al.
Cephalalgia : an International Journal of Headache|December 3, 2020
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a <i>post-hoc</i> analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extensionRichard B Lipton, Stewart J Tepper, Stephen D Silberstein, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 1, 1978
Proton irradiation of choroidal melanomas. Preliminary resultsE S Gradoudas, M Goitein, A Koehler, et al.
Headache|January 27, 2023
Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trialStewart J Tepper, Liron Rabany, Robert P Cowan, et al.
Pageof 44

Showing results (401-410 of 432) with videos related to

Sort By:
Pageof 44
Headache|March 16, 2013
Ictal adiponectin levels in episodic migraineurs: a randomized pilot trialB Lee Peterlin, Gretchen E Tietjen, Barbara A Gower, et al.
Headache|December 14, 2020
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2Hans-Christoph Diener, Michael J Marmura, Stewart J Tepper, et al.
Frontiers in Neurology|August 21, 2024
Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodiesAni C Khodavirdi, Jasjit K Multani, Sam S Oh, et al.
Cancer|August 1, 1983
Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremitiesS A Rosenberg, J Tepper, E Glatstein, et al.
The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.
Frontiers in Neurology|March 13, 2023
Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION-A phase 4, multinational, randomized, double-blind, placebo-controlled studyRigmor H Jensen, Henrik Winther Schytz, Cristina Tassorelli, et al.
JAMA Neurology|May 19, 2025
Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical TrialRigmor H Jensen, Cristina Tassorelli, Stewart J Tepper, et al.
Cephalalgia : an International Journal of Headache|December 3, 2020
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a <i>post-hoc</i> analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extensionRichard B Lipton, Stewart J Tepper, Stephen D Silberstein, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 1, 1978
Proton irradiation of choroidal melanomas. Preliminary resultsE S Gradoudas, M Goitein, A Koehler, et al.
Headache|January 27, 2023
Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trialStewart J Tepper, Liron Rabany, Robert P Cowan, et al.
Pageof 44